Impact of early vs late postoperative radioiodine remnant ablation on final outcome in patients with low‐risk well‐differentiated thyroid cancer

scientific article published on August 21, 2013

Impact of early vs late postoperative radioiodine remnant ablation on final outcome in patients with low‐risk well‐differentiated thyroid cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/CEN.12301
P953full work available online athttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fcen.12301
https://onlinelibrary.wiley.com/doi/pdf/10.1111/cen.12301
P698PubMed publication ID23895145

P2093author name stringStylianos Tsagarakis
Ioannis Datseris
George Ioannidis
Marinella Tzanela
Varvara Vlassopoulou
Charalambos Vassilopoulos
Panagiotis Trivizas
Sofia Tsirona
Phoebe Rondogianni
Efthimia Botoula
P2860cites workRevised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancerQ28262641
Cancer statistics, 2009Q29547625
Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patientsQ34523261
The management of thyroid cancer in adults: a review of new guidelines.Q34625169
Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapyQ35163702
Clinical review 170: A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancerQ35855096
Differentiated thyroid cancer: management of patients with radioiodine nonresponsive diseaseQ35864072
Use of Radioactive Iodine for Thyroid CancerQ35961413
The evolving role of (131)I for the treatment of differentiated thyroid carcinomaQ36011259
Invasive well-differentiated thyroid carcinoma: effect of treatment modalities on outcomeQ36463600
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epitheliumQ36489842
Disease Severity and Radioactive Iodine Use for Thyroid CancerQ36589440
Thyroid cancer: a lethal endocrine neoplasmQ37768662
The Effectiveness of Radioactive Iodine for Treatment of Low-Risk Thyroid Cancer: A Systematic Analysis of the Peer-Reviewed Literature from 1966 to April 2008Q37808222
Low iodine diet in I-131 ablation of thyroid remnants.Q42464889
Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I : practice recommendations of the American Thyroid Association.Q43583798
Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid CancerQ47820717
Strategies of radioiodine ablation in patients with low-risk thyroid cancerQ47820730
Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005.Q51134475
Delayed initial radioactive iodine therapy resulted in poor survival in patients with metastatic differentiated thyroid carcinoma: a retrospective statistical analysis of 198 casesQ51474895
Clinical features and prognostic factors for survival in patients with poorly differentiated thyroid carcinoma and comparison to the patients with the aggressive variants of papillary thyroid carcinomaQ53574880
Evaluation of low-dose radioiodine ablation therapy in postsurgical thyroid cancer patientsQ54441394
Comparison of 30- and 50-mCi doses of iodine-131 for thyroid ablationQ70264985
Effects of low-iodide diet on postsurgical radioiodide ablation therapy in patients with differentiated thyroid carcinomaQ73138058
Ablation of the thyroid remnant and 131I dose in differentiated thyroid cancerQ73883538
Radiation protection legislationQ74213624
Radioiodine therapy in patients with stage I differentiated thyroid cancerQ82331530
Increasing incidence of thyroid cancer in the United States, 1973-2002Q83310394
Impact on Overall Survival of Radioactive Iodine in Low-Risk Differentiated Thyroid Cancer PatientsQ83464243
P433issue3
P407language of work or nameEnglishQ1860
P304page(s)459-463
P577publication date2013-08-21
P1433published inClinical EndocrinologyQ15762781
P1476titleImpact of early vs late postoperative radioiodine remnant ablation on final outcome in patients with low-risk well-differentiated thyroid cancer
Impact of early vs late postoperative radioiodine remnant ablation on final outcome in patients with low‐risk well‐differentiated thyroid cancer
P478volume80

Reverse relations

cites work (P2860)
Q55339181Clinical outcomes and associated factors of radioiodine-131 treatment in differentiated thyroid cancer with cervical lymph node metastasis.
Q36716987Risk Factors Associated with Disease Recurrence among Patients with Low-Risk Papillary Thyroid Cancer Treated at the University of the Philippines-Philippine General Hospital
Q38783191Thyroid nodules and cancer management guidelines: comparisons and controversies
Q88657950Use of radioiodine-131 scan to measure influence of surgical discipline, practice, and volume on residual thyroid tissue after total thyroidectomy for differentiated thyroid carcinoma

Search more.